Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

被引:112
作者
Chen, Z
Sahashi, Y
Matsuo, K
Asanuma, H
Takahashi, H
Iwasaki, T
Suzuki, Y
Aizawa, C
Kurata, T
Tamura, S
机构
[1] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 162, Japan
[2] Kitasato Inst, Biol Res Ctr, Kitamoto, Saitama 364, Japan
关键词
DNA vaccine; influenza; hemagglutinin; neuraminidase;
D O I
10.1016/S0264-410X(98)00043-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability of plasmid DNA encoding various influenza viral proteins from the A/PR/8/34 (H1N1) virus to protect against influenza was compared in BALB/c mice. The plasmid DNA encoded hemagglutinin (HA), neuraminidase (NA), matrix protein (M1), nucleoprotein (NP) or nonstructural protein (NS1) in a chicken beta-actin-based expression vector (pCAGGS). Each DNA was inoculated twice 3 weeks apart at a dose of 1 mu g per mouse by particle-mediated DNA transfer to the epidermis (gene gun). Seven days after a second immunization, mice were challenged with the homologous virus and the ability, of each DNA to protect mice from influenza was evaluated by decreased lung virus titers and increased survival. Mice, given HA- or NA-expressing DNA, induced a high level of specific antibody response and protected well against the challenge virus. On the other hand, mice given M1-, NP-, or NS1-DNA failed to provide protection, although M1- and NP-DNAs did induce detectable antibody responses. These results indicate that both HA- and NA-expressing DNAs for the surface glycoproteins are most protective against influenza from among the various viral protein-expressing DNAs used here. (C) 1998 Elsevier Science Ltd All rights reserved.
引用
收藏
页码:1544 / 1549
页数:6
相关论文
共 25 条
[1]   Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza [J].
Bender, BS ;
Rowe, CA ;
Taylor, SF ;
Wyatt, LS ;
Moss, B ;
Small, PA .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6418-6424
[2]  
DAVENPORT FM, 1964, J LAB CLIN MED, V63, P5
[3]   Recombinant neuraminidase vaccine protects against lethal influenza [J].
Deroo, T ;
Jou, WM ;
Fiers, W .
VACCINE, 1996, 14 (06) :561-569
[4]   PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS [J].
DONNELLY, JJ ;
FRIEDMAN, A ;
MARTINEZ, D ;
MONTGOMERY, DL ;
SHIVER, JW ;
MOTZEL, SL ;
ULMER, JB ;
LIU, MA .
NATURE MEDICINE, 1995, 1 (06) :583-587
[5]  
EPSTEIN SL, 1993, J IMMUNOL, V150, P5484
[6]   DNA VACCINES - PROTECTIVE IMMUNIZATIONS BY PARENTERAL, MUCOSAL, AND GENE-GUN INOCULATIONS [J].
FYNAN, EF ;
WEBSTER, RG ;
FULLER, DH ;
HAYNES, JR ;
SANTORO, JC ;
ROBINSON, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11478-11482
[7]   IMMUNIZATION WITH PURIFIED N1 AND N2 INFLUENZA-VIRUS NEURAMINIDASES DEMONSTRATES CROSS-REACTIVITY WITHOUT ANTIGENIC-COMPETITION [J].
JOHANSSON, BE ;
KILBOURNE, ED .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2358-2361
[8]   Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza a virus eliminates cognate help and antigenic competition [J].
Johansson, BE ;
Kilbourne, ED .
VIROLOGY, 1996, 225 (01) :136-144
[9]   Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization [J].
Kuklin, N ;
Daheshia, M ;
Karem, K ;
Manickan, E ;
Rouse, BT .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3138-3145
[10]  
NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D